Biomarin Pharmaceutical Inc (BMRN)

08:41 AM

Bernstein lowers BioMarin stock price target to $88 on growth concerns - Investing.com Nigeria

08:41 AM

06:50 AM

Eleva Capital SAS Invests $1.29 Million in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat

06:50 AM

06:36 AM

Is BioMarin Pharmaceutical Inc. (BM8) stock cheap by valuation metricsDollar Strength & Weekly Stock Performance Updates - newser.com

06:36 AM

05:08 AM

Will BioMarin Pharmaceutical Inc. (BM8) stock hit analyst forecastsQuarterly Profit Summary & Low Risk Entry Point Tips - newser.com

05:08 AM

03:55 AM

Keybank National Association OH Sells 19,707 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat

03:55 AM

12:31 PM

The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call - TradingView

12:31 PM

Nov 02, 2025

Can BioMarin Pharmaceutical Inc. stock hit analyst price targets2025 Buyback Activity & Consistent Profit Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

How to manage a losing position in BioMarin Pharmaceutical Inc.Day Trade & Fast Momentum Entry Tips - newser.com

Nov 02, 2025

Nov 02, 2025

Exit strategy if you’re trapped in BioMarin Pharmaceutical Inc.July 2025 Fed Impact & Real-Time Market Trend Scan - newser.com

Nov 02, 2025

Nov 02, 2025

How strong is BioMarin Pharmaceutical Inc. stock balance sheetMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat

Nov 02, 2025

Nov 01, 2025

What is William Blair's Estimate for BMRN Q4 Earnings? - MarketBeat

Nov 01, 2025

Nov 01, 2025

Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 14,700 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat

Nov 01, 2025

Nov 01, 2025

Can BioMarin Pharmaceutical Inc. (BM8) stock reach $200 price targetOptions Play & Weekly Return Optimization Plans - newser.com

Nov 01, 2025

Nov 01, 2025

Why BioMarin Pharmaceutical Inc. stock is in analyst buy zoneWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com

Nov 01, 2025

Nov 01, 2025

Why BioMarin Pharmaceutical Inc. stock is seen as undervaluedJobs Report & Free Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025

Oct 31, 2025

Morgan Stanley Maintains Buy on BioMarin Pharmaceutical (BMRN) - MSN

Oct 31, 2025

Oct 31, 2025

BioMarin Pharmaceutical (BMRN): Evaluating Valuation as Shares Recover 3% After Prolonged Downtrend - Sahm

Oct 31, 2025

Oct 31, 2025

How to monitor BioMarin Pharmaceutical Inc. with trend dashboards2025 Valuation Update & High Yield Stock Recommendations - newser.com

Oct 31, 2025

Oct 31, 2025

10 Best Beaten Down Growth Stocks to Buy According to Analysts - Insider Monkey

Oct 31, 2025

Oct 31, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 12-Month LowWhat's Next? - MarketBeat

Oct 31, 2025

Oct 31, 2025

Cantor Fitzgerald Has Negative View of BMRN FY2025 Earnings - MarketBeat

Oct 31, 2025

Oct 31, 2025

How currency fluctuations impact BioMarin Pharmaceutical Inc. stock2025 Technical Overview & Safe Swing Trade Setups - newser.com

Oct 31, 2025

Oct 31, 2025

How to read the order book for BioMarin Pharmaceutical Inc.Market Activity Report & Daily Profit Focused Stock Screening - newser.com

Oct 31, 2025

Oct 31, 2025

Sentiment analysis tools applied to BioMarin Pharmaceutical Inc.Global Markets & AI Enhanced Trading Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

BioMarin Pharmaceutical (BMRN) Announces Financial Results for Q3 2025 - Insider Monkey

Oct 30, 2025

Oct 30, 2025

13 Stocks to Buy with Exponential Growth Heading into 2026 - Insider Monkey

Oct 30, 2025

Oct 30, 2025

BioMarin Pharmaceutical Inc. Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance

Oct 30, 2025

Oct 30, 2025

Earnings Miss: BioMarin Pharmaceutical Inc. Missed EPS And Analysts Are Revising Their Forecasts - simplywall.st

Oct 30, 2025

Oct 30, 2025

Biomarin Pharmaceutical stock hits 52-week low at 51.52 USD By Investing.com - Investing.com South Africa

Oct 30, 2025

Oct 30, 2025

After a futile battle, Biomarin will sell the bleeding disorder drug Roctavian - medwatch.com

Oct 30, 2025

Oct 30, 2025

Biomarin Pharmaceutical stock hits 52-week low at 51.52 USD - Investing.com

Oct 30, 2025

Oct 30, 2025

Cantor Fitzgerald Issues Negative Forecast for BMRN Earnings - MarketBeat

Oct 30, 2025

Oct 30, 2025

BioMarin Pharma plans to divest struggling gene therapy - MSN

Oct 30, 2025

Oct 29, 2025

Results: BioMarin Pharmaceutical Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts - 富途牛牛

Oct 29, 2025

Oct 29, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Earns Outperform Rating from Wedbush - MarketBeat

Oct 29, 2025

Oct 29, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $70.00 by Analysts at Wells Fargo & Company - MarketBeat

Oct 29, 2025

Oct 29, 2025

Stifel Nicolaus Cuts BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $73.00 - MarketBeat

Oct 29, 2025

Oct 29, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $80.00 at Barclays - MarketBeat

Oct 29, 2025